Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Imaxio Logo
Imaxio Growth Score
76
CB Rank
490730
Heat Score
25
Imaxio is a France-based biopharmaceutical company specialized in vaccines and genomics.
Founded
obfuscation
PrivateSeries A Lyon, Rhone-Alpes, France11-50 www.imaxio.com
Biopharma
Biotechnology
Clinical Trials
Overview

Imaxio
Total Funding
obfuscation
Growth Score
76
Heat Score
25

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score76
-1 pts
in past quarter
Heat Score 25
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Imaxio

CB Rank
490730
Imaxio is a France-based biopharmaceutical company specialized in vaccines and genomics.
Founded
obfuscation
PrivateSeries A Lyon, Rhone-Alpes, France11-50 www.imaxio.com
Biopharma
Biotechnology
Clinical Trials

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Imaxio S.A.
Operating Status Active
Company Type For Profit
About the Company
Imaxio, a Lyon, and Saint Beauzire, France-based biopharmaceutical company specialized in the areas of vaccines and genomics
Phone Number 33474261578
Contact Email contact@imaxio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Spirolept®
A vaccine containing inactivated Leptospira icterohaemorrhagiae, used for the prevention of leptospirosis.
oligoDOM® technology
A pro-immunogenic technology used in the development of vaccines and immunotherapies, including applications in tuberculosis and malaria.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A
obfuscation
Series A - Imaxio Logo
Series A - Imaxio
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$370.6KThis year, Imaxio is projected to spend $370.6K on IT, according to Aberdeen.

Actively Used Products

12Imaxio uses 12 technology products and services including HTML5, Microsoft Outlook, and  Office 365, according to G2 Stack.

Active Website Tech Count

28Imaxio is actively using 28 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

2The intellectual property of Imaxio includes 2 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Imaxio's headquarters? Imaxio is located in Lyon, Rhone-Alpes, France.When was the last funding round for Imaxio? Imaxio closed its last funding round on
obfuscation
from a Series A round.Who are Imaxio's competitors? Alternatives and possible competitors to Imaxio may include Sanofi, Zoetis, and  Elanco.How much funding has Imaxio raised to date? Imaxio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|